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Background: Cocaine is a potent sympathomimetic agent associated with the development of possible fatal
cardiovascular complications. Dysrhythmias, acute myocardial infarction, hypertension and dilated cardiomyopathy
are just some of many cardiovascular effects related to the abuse of cocaine.
Case presentation: A 38-year-old Hispanic male with a past medical history of hypertension presented with a chief
complaint of progressive shortness of breath. The patient confessed to the use of cocaine for almost 18 years once
per week. On examination he was hypertensive and tachycardic with a systolic murmur over the 5th intercostal
space at the level of the left mid-clavicular line. Laboratory workup revealed an elevated Brain natriuretic peptide;
urine toxicology was positive for cocaine. 2D-echocardiogram showed dilated cardiomyopathy. Cardiac
catheterization excluded angioischemic cause. He was managed medically and subsequently discharged with drug
rehabilitation. On follow-up diagnostic evaluation after 5 months of cocaine cessation, his ejection function
improved significantly.
Conclusion: The exact incidence of cocaine related cardiomyopathy is unknown and likely underreported. The clinical
course is abrupt and comparatively similar to other types of cardiomyopathy. The management is like other forms of
cardiomyopathy; however β-blockers should be avoided. The myocardial dysfunction is reversible with abstaining from
additional cocaine ingestion. Non-invasive testing should be performed after several months to re-evaluate the
treatment response.
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More than 14 million people worldwide, mostly within
the age range of 15 to 64 years, consume cocaine. Men
of 15–35 years represent the majority. Dose-dependent
tachycardia, hypertension along with increased arousal is
the first physiological response to cocaine use. Perform-
ance improvement, attentiveness, sense of positive self-
image and euphoria often accompany the cumulative
use of cocaine. End-organ-damage associated with co-
caine can affect almost every organ system. In the United
States cocaine, beside alcohol, is the most frequent cause
of drug-associated emergency department (ED) visits.* Correspondence: german.hernandez@ttuhsc.edu
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stated.Cocaine results in a gradual addiction due to it vigorous
sympathomimetic features with possible destructive
cardiovascular effects. Cardiovascular complications ac-
count for a massive economic debt on the United States
healthcare system. Dysrhythmias, acute myocardial infarc-
tion, myocarditis, hypertension, endocarditis, hypotensive
shock, cerebral vascular accidents and dilated cardiomy-
opathy are several cardiovascular complications due to co-
caine abuse [1].
Cocaine blocks the presynaptic dopamine and cat-
echolamine uptake, resulting in post-synaptic sympa-
thetic stimulation and dopaminergic receptor activation
[2]. Peripheral vasoconstriction results in hypertension,
tachycardia and an increase in afterload. Arrhythmias
are likely to occur due to the altered autonomic action
and cardiovascular resistance results in a decreased
myocardial blood supply [3]. Negative inotropic events
can also occur from cocaine abuse. Hypertrophy of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Cooper et al. BMC Research Notes 2013, 6:536 Page 2 of 4
http://www.biomedcentral.com/1756-0500/6/536left ventricle and cardiomyopathy with significant reduc-
tion of the ejection fraction has been described in the
setting of chronic cocaine consumption. Myocardial
hypertrophy is likely to occur secondary to the tempor-
ary blood pressure elevation after cocaine use [4]. Smok-
ing and alcohol use exacerbate the cardiotoxic impact
of cocaine [5]. The unfavorable economic impact and
awareness of the possible cardiovascular effects should be
considered during the initial evaluation when young adults
with heart failure symptomatology present for medical
assessment.
Case presentation
A 38-year-old Hispanic male presented with progressive
dyspnea at rest since the morning, which became worse
with exertion and lying flat. Similar episodes were also
noticed approximately one month ago. During this time
he was hospitalized for community-acquired-pneumonia
and was discharged three days later. His other complaints
included productive cough with whitish blood-tinged
sputum, frontal headache, mild subjective fever and
mid-sternal chest discomfort. Past medical history in-
cluded only hypertension. No home medications were
used. He confessed to regularly using cocaine once per
week of various amounts for the last 18 years. His last co-
caine use was on the night before admission. Other social
history included occasional cigarette smoking, but no al-
cohol or intravenous drug use. He denied hazardous
exposure.
Initial vital signs revealed a tachycardic (heart rate: 104–
110 beats per minute) and hypertensive (blood pressure:
179/121 mmHg) patient, with peripheral oxygen satur-
ation of 86–89% on 2 L nasal cannula. Pertinent physical
examination finding revealed multiple tattoos, mild nasal
erythema without perforation signs of the nasal septum
and a previous exploratory laparotomy scar (stab wound
several years ago). Cardiovascular and lung examination
were significant for jugular vein distention, tachycardia,
2/6 systolic murmur at mitral valve area with radiation to
the left axilla and bilateral diffuse coarse crackles. Initial
laboratory workup at admission was insignificant except
for elevated brain nautriuretic peptide of 894 ng/L and
positive urine toxicology screen for cocaine. Electrocardio-
gram on admission showed sinus tachycardia; left atrial
enlargement, left ventricular hypertrophy and nonspecific
T wave abnormalities over the anterior wall leads. Chest
X-ray (Figure 1) showed bilateral patchy opacities repre-
senting pulmonary edema or possible hemorrhage. Com-
puted tomography of chest (Figure 2) revealed
bilateral peribronchovascular airspace consolidation,
ground-glass opacity with interlobular septal thicken-
ing and small bilateral pleural effusions. Our differential
included an etiology causing pulmonary edema versus a
less likely pulmonary hemorrhage or atypical infection.Due to his recent use of cocaine β-blockers were not
used to control the hypertension however we opted to use
amlodipine 10 mg daily instead. Pulmonary team was con-
sulted; the impression was consistent with pulmonary
edema from questionable congestive heart failure (CHF),
which could have been from the history of cocaine use ra-
ther than a primary pulmonary cause. The recommenda-
tions included initiating a treatment with a diuretic agent,
vasodilators and obtaining 2D-echocardiogram. Manage-
ment consisted of amlodipine 10 mg daily, furosemide
20 mg twice daily, hydralazine 10 mg daily and lisinopril
10 mg daily. The 2D echocardiogram showed moderate
left ventricle dilation (left ventricular end diastolic dimen-
sion LVEDD of 6.3 cm) without signs of apical ballooning;
the left atrium with 4.9 cm moderate-severely dilated,
moderate global hypokinesis of the left ventricle with an
ejection fraction of 25%, stage 3 diastolic dysfunction and
mild to moderate mitral regurgitation (Additional files 1,
2, 3, 4, 5 and 6). By the 4th day he was clinically asymp-
tomatic and the pulmonary examination was unremark-
able. Repeat chest x-ray showed almost complete
resolution of bilateral patchy airspace consolidation phe-
nomena however with some bibasilar persistence. The car-
diology team was consulted for further recommendations,
cardiac catheterization and the possibility of implantable
cardioverter defibrillator (ICD) placement. The patient
was taken for cardiac catheterization on hospital day 5
and ischemic cardiomyopathy was ruled out. An associ-
ation between his symptoms and the binge consuming of
cocaine was established. Cardiac biopsy was not recom-
mended at this time. Re-evaluation of all the above find-
ings including reconsidering a cardiac biopsy 5 months
after the discharge was arranged. On the 6th day, the
psychiatry service counseled the patient; he agreed to
undergo a rehabilitation course in an inpatient institution.
On the following day he was transferred to the rehabilita-
tion center on his CHF medications.
Five months later and after successful completing of
the treatment course at the rehabilitation center the pa-
tient was re-evaluated. Repeat echocardiogram was per-
formed and showed an improved ejection fraction of 50-
55%, improvement of the previously dilated size of the
left ventricle (LVEDD from 6.3 cm to 5.4 cm) and mild-
moderately dilated left atrium of 4.5 cm. The clinical
condition was remarkably better, echocardiographic geo-
metric changes partially resolved. Beta-blocker was
added; cardiac biopsy was not done. Evidences for the
strong association between previous cocaine abuse and
newly diagnosed CHF were clinically confirmed.
Discussion
The precise incidence of cocaine induced cardiomyop-
athy remains mysterious and probably underreported.
The mechanism leading to develop cocaine-induced
Figure 1 Chest X-ray- bilateral patchy opacities.
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development of a coronary thrombus, increased oxida-
tive stress, calcium flux sympathomimetic effects are
contributing factors in its pathophysiologic formation
[6]. The duration and quantity of cocaine use required
to develop a subsequent cardiomyopathy is presently not
clear. Cocaine induced cardiomyopathy occurs unex-
pectedly and without any significant prodrome [7]. Clin-
ical manifestations are similar to other types of dilated
cardiomyopathy. Presentation symptomatology can be
nausea, dizziness, anxiety, dyspnea and palpitations.
Only a few cases have been reported in the literature
that describes a reversal of the cardiomyopathy after co-
caine cessation in a young male that chronically used co-
caine [8]. As described in our case, cocaine induced
cardiomyopathy should always be considered when
young male patients present with signs of left ventricular
dysfunction, adrenergic excess or heart failure.
Typical echocardiographic features include a high left
ventricular mass index, increased left ventricular mass andFigure 2 Computed tomography of the chest without contrast - bilat
opacity with interlobular septal thickening.left ventricular dysfunction [8]. However it is difficult
based on only the echocardiogram to distinguish it from
other types of cardiomyopathy. The therapy of cocaine-
induced cardiomyopathy is similar to the way that other
types of cardiomyopathy are managed. Beta-blockers
should not be considered initially; benzodiazepine is pre-
ferred to counteract the adrenergic effect. In the acute set-
ting the addition of beta-blockers will adversely result in
the alpha-adrenergic receptors being unopposed, therefore
leading to coronary vasoconstriction, left ventricle wall
stress and a hypertensive crisis [9]. As recommended in
other types of cardiomyopathy, pharmacological agents
such as, diuretics Angiotensin-Converting-Enzyme Inhibi-
tors, Angiotensin-Receptor Blocker, vasodilators, or
digoxin should be initially included.
It is strongly urged to consider a cardiology consult-
ation during the hospital stay. By abstaining from co-
caine use, the possibility of a favorable myocardial
function reversibility is likely. However no functional
improvement is expected if permanent myocardialeral peribronchovascular airspace consolidation, ground-glass
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patient is clinically stabilized, hospitalization for detoxifi-
cation, psychiatric management to evaluate the need for
pharmacotherapy, psychotherapy or counselling are
highly recommended. Furthermore, it is suggested that
repeat noninvasive testing to be performed after sev-
eral months, preferably 4–8 months, to evaluate the
myocardial functional response to medical therapy
and cocaine cessation.
Conclusion
Cocaine use should be considered if young patients pre-
sented with heart failure, mainly without other underlying
risk factors. It is important to counsel these patients re-
garding the deleterious effects of cocaine abuse and the
potential reversal of cardiac dysfunction with abstaining
from the cocaine use.
Consent
“Written informed consent was obtained from the pa-
tient for publication of this case report and accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal”.
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Additional file 3: Left ventricle apical four-chamber view representing
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Additional file 4: Color-doppler of the left ventricle apical four-chamber
view showing he mild-moderate mitral regurgitation.
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Additional file 6: Left ventricle two-chamber view representing
again the diffuse severely reduced ejection fraction.
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